Essex Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,360
| Closed | -$957K | – | 393 |
|
|
2023
Q2 | $957K | Buy |
+20,360
| New | +$957K | 0.13% | 214 |
|
|
2019
Q3 | – | Sell |
-6,332
| Closed | -$1.16M | – | 498 |
|
|
2019
Q2 | $1.16M | Buy |
+6,332
| New | +$1.16M | 0.16% | 200 |
|
|
2019
Q1 | – | Sell |
-9,961
| Closed | -$954K | – | 510 |
|
|
2018
Q4 | $954K | Buy |
9,961
+6,319
| +174% | +$605K | 0.15% | 201 |
|
|
2018
Q3 | $514K | Sell |
3,642
-1,460
| -29% | -$206K | 0.06% | 293 |
|
|
2018
Q2 | $799K | Buy |
5,102
+173
| +4% | +$27.1K | 0.1% | 246 |
|
|
2018
Q1 | $794K | Sell |
4,929
-1,502
| -23% | -$242K | 0.1% | 238 |
|
|
2017
Q4 | $1.06M | Sell |
6,431
-395
| -6% | -$65K | 0.14% | 209 |
|
|
2017
Q3 | $425K | Sell |
6,826
-24,834
| -78% | -$1.55M | 0.06% | 279 |
|
|
2017
Q2 | $2.52M | Buy |
31,660
+787
| +3% | +$62.7K | 0.36% | 83 |
|
|
2017
Q1 | $2.19M | Buy |
30,873
+19,204
| +165% | +$1.36M | 0.34% | 77 |
|
|
2016
Q4 | $596K | Buy |
+11,669
| New | +$596K | 0.1% | 231 |
|